LTC1334091I2 - Tioflavino dariniai ir jų panaudojimas Alzhaimerio ligos diagnostikai ir terapijai - Google Patents
Tioflavino dariniai ir jų panaudojimas Alzhaimerio ligos diagnostikai ir terapijaiInfo
- Publication number
- LTC1334091I2 LTC1334091I2 LTPA2015001C LTPA2015001C LTC1334091I2 LT C1334091 I2 LTC1334091 I2 LT C1334091I2 LT PA2015001 C LTPA2015001 C LT PA2015001C LT PA2015001 C LTPA2015001 C LT PA2015001C LT C1334091 I2 LTC1334091 I2 LT C1334091I2
- Authority
- LT
- Lithuania
- Prior art keywords
- alzheimer
- diagnosis
- therapy
- disease
- thioflavin derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
- C07D277/66—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2 with aromatic rings or ring systems directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicinal Preparation (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Nuclear Medicine (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22760100P | 2000-08-24 | 2000-08-24 | |
PCT/US2001/026427 WO2002016333A2 (en) | 2000-08-24 | 2001-08-24 | Thioflavin derivatives and their use in diagnosis and theraphy of alzheimer's disease |
Publications (2)
Publication Number | Publication Date |
---|---|
LTPA2015001I1 LTPA2015001I1 (lt) | 2015-02-25 |
LTC1334091I2 true LTC1334091I2 (lt) | 2018-05-25 |
Family
ID=22853739
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LTPA2015001C LTC1334091I2 (lt) | 2000-08-24 | 2015-01-19 | Tioflavino dariniai ir jų panaudojimas Alzhaimerio ligos diagnostikai ir terapijai |
Country Status (19)
Country | Link |
---|---|
US (5) | US20020133019A1 (lt) |
EP (2) | EP2264018B1 (lt) |
JP (2) | JP5022554B2 (lt) |
CN (1) | CN1285582C (lt) |
AU (3) | AU8670201A (lt) |
BR (1) | BRPI0113470B8 (lt) |
CA (1) | CA2419420C (lt) |
CY (1) | CY1113311T1 (lt) |
DK (2) | DK2264018T3 (lt) |
ES (2) | ES2536449T3 (lt) |
HK (2) | HK1058041A1 (lt) |
HU (2) | HU230581B1 (lt) |
LT (1) | LTC1334091I2 (lt) |
NO (1) | NO330176B1 (lt) |
PL (1) | PL215711B1 (lt) |
PT (2) | PT2264018E (lt) |
RU (1) | RU2324686C2 (lt) |
SI (1) | SI1334091T1 (lt) |
WO (1) | WO2002016333A2 (lt) |
Families Citing this family (112)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6689753B1 (en) * | 1999-11-05 | 2004-02-10 | Axonyx, Inc. | β sheet breaker peptide analogs that inhibit β pleated sheet formation in amyloid β-peptide |
EP1266884A4 (en) * | 2000-03-22 | 2003-04-23 | Bf Res Inst Inc | IMAGE DIAGNOSIS PROBE, BASED ON SUBSTITUTED AZOBENZOL OR ITS ANALOGA, FOR DISEASES WHICH ARE ATTRIBUTED TO AMYLOID ACCUMULATION, AND MIXTURES CONTAINING THIS IMAGE |
US7297326B2 (en) * | 2000-08-21 | 2007-11-20 | The General Hospital Corporation | Ocular diagnosis of Alzheimer's disease |
EP2151187A1 (en) | 2000-08-21 | 2010-02-10 | The General Hospital Corporation | Methods for diagnosing a neurodegenerative condition |
PT2264018E (pt) * | 2000-08-24 | 2015-06-03 | Univ Pittsburgh | Derivados de tioflavina para uso no diagnóstico da doença de alzheimer |
US7270800B2 (en) | 2000-08-24 | 2007-09-18 | University Of Pittsburgh | Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
CA2427014A1 (en) * | 2000-11-02 | 2002-08-22 | Cornell Research Foundation, Inc. | In vivo multiphoton diagnostic detection and imaging of a neurodegenerative disease |
EP1345914A1 (en) * | 2000-12-22 | 2003-09-24 | AstraZeneca AB | Therapeutic compounds |
GB0106953D0 (en) | 2001-03-20 | 2001-05-09 | Univ Aberdeen | Neufofibrillary labels |
US20060106074A1 (en) * | 2001-11-28 | 2006-05-18 | Peter Bernstein | Er-b-selective ligands |
US6774248B2 (en) | 2001-12-18 | 2004-08-10 | Wyeth | Substituted 2-phenyl benzofurans as estrogenic agents |
EP1820806A1 (en) * | 2006-02-16 | 2007-08-22 | Crossbeta Biosciences B.V. | Affinity regions |
US7008958B2 (en) | 2002-05-21 | 2006-03-07 | Bristol-Myers Squibb Company | 2-substituted 5-oxazolyl indole compounds useful as IMPDH inhibitors and pharmaceutical compositions comprising same |
WO2003106439A1 (ja) * | 2002-06-12 | 2003-12-24 | 株式会社ビーエフ研究所 | アミロイド蓄積性疾患の画像診断プローブ化合物、老人斑/びまん性老人斑染色用化合物、ならびにアミロイド蓄積性疾患の治療薬 |
US20070003552A1 (en) * | 2002-07-09 | 2007-01-04 | Gebbink Martijn F B | Cross-beta structure comprising amyloid binding proteins and methods for detection of the cross-beta structure, for modulating cross-beta structures fibril formation and for modulating cross-beta structure-mediated toxicity and method for interfering with blood coagulation |
EP1380290A1 (en) * | 2002-07-09 | 2004-01-14 | Universitair Medisch Centrum Utrecht | Cross-beta structure pathway and its therapeutic relevance |
EP1547996A4 (en) * | 2002-08-30 | 2006-08-02 | Bf Res Inst Inc | DIAGNOSTIC PROBES AND REMEDIES FOR DISEASES HAVING PRION PROTEIN ACCUMULATION AND METHOD OF MARKING |
DE60323155D1 (de) | 2002-12-19 | 2008-10-02 | Scripps Research Inst | Von transthyretin und zur hemmung von transthyretin-fehlfaltung |
GB0229686D0 (en) | 2002-12-20 | 2003-01-29 | Amersham Plc | Solid-phase fluorination of benzothiazoles |
CA2438032C (en) * | 2003-03-14 | 2013-05-07 | University Of Pittsburgh | Benzothiazole derivative compounds, compositions and uses |
CN102532055B (zh) * | 2003-03-14 | 2016-05-11 | 匹兹堡大学联邦制高等教育 | 苯并噻唑衍生物化合物、组合物及用途 |
GB0307855D0 (en) * | 2003-04-04 | 2003-05-14 | Novartis Ag | Organic compounds |
US20040223912A1 (en) * | 2003-05-07 | 2004-11-11 | Montalto Michael Christopher | Compositions and methods for non-invasive imaging of soluble beta-amyloid |
EP1631561B1 (en) | 2003-05-07 | 2010-08-18 | General Electric Company | Compositions and methods for non-invasive imaging of soluble beta-amyloid |
AU2003304416A1 (en) * | 2003-08-13 | 2005-03-07 | Bf Research Institute, Inc. | Probe for disease with amyloid deposit, amyloid-staining agent, remedy and preventive for disease with amyloid deposit and diagnostic probe and staining agent for neurofibril change |
CA2500358A1 (en) * | 2003-08-13 | 2005-02-24 | Bf Research Institute, Inc. | Probes for diseases in which amyloid accumulates, agents for staining amyloid, drugs for treatment and prophylaxis of diseases with accumulated amyloid, and probes for diagnosis of neurofibrillary tangles and agents for staining neurofibrillary tangles |
US8236282B2 (en) | 2003-08-22 | 2012-08-07 | University of Pittsburgh—of the Commonwealth System of Higher Education | Benzothiazole derivative compounds, compositions and uses |
JP3877754B2 (ja) * | 2003-10-30 | 2007-02-07 | 株式会社同仁化学研究所 | アミロイド親和性化合物 |
EP1719529A4 (en) * | 2004-02-25 | 2008-05-21 | Astellas Pharma Inc | CONTRASTING FOR THROMBUS EDUCATION |
JP5039541B2 (ja) | 2004-04-27 | 2012-10-03 | ワイス・エルエルシー | プロゲステロン受容体調節剤の精製 |
GB0410448D0 (en) | 2004-05-11 | 2004-06-16 | Hammersmith Imanet Ltd | Purification methods |
US20080319175A1 (en) | 2004-05-20 | 2008-12-25 | The Scripps Research Institute | Transthyretin Stabilization |
CA2587248C (en) * | 2004-07-02 | 2014-01-07 | William E. Klunk | Amyloid imaging as a surrogate marker for efficacy of anti-amyloid therapies |
US20080286202A1 (en) * | 2004-07-02 | 2008-11-20 | University Of Pittsburgh | Method of Diagnosing Prodromal Forms of Diseases Associated With Amyloid Deposition |
EA200700243A1 (ru) | 2004-07-14 | 2007-08-31 | ПиТиСи ТЕРАПЬЮТИКС, ИНК. | Способы лечения гепатита с |
US7868037B2 (en) | 2004-07-14 | 2011-01-11 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
US7781478B2 (en) | 2004-07-14 | 2010-08-24 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
US7772271B2 (en) | 2004-07-14 | 2010-08-10 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
CA2573819A1 (en) * | 2004-07-15 | 2006-02-23 | The General Hospital Corporation | Heterocyclic dye compounds for in vivo imaging and diagnosis of alzheimer's disease |
WO2006019832A1 (en) | 2004-07-22 | 2006-02-23 | Ptc Therapeutics, Inc. | Thienopyridines for treating hepatitis c |
CN101262881A (zh) * | 2005-07-13 | 2008-09-10 | 交叉β生物科学有限公司 | 通过交叉β结构的佐剂化 |
WO2007008072A2 (en) | 2005-07-13 | 2007-01-18 | Crossbeta Biosciences B.V. | CROSS-ß STRUCTURE BINDING COMPOUNDS |
US20070015133A1 (en) * | 2005-07-13 | 2007-01-18 | Umc Utrecht Holding B.V. | Method for detecting and/or removing protein and/or peptide comprising a cross-beta structure from an aqueous solution comprising a protein |
US8114832B2 (en) * | 2005-07-13 | 2012-02-14 | Crossbeta Biosciences B.V. | Method for detecting and/or removing a protein comprising a cross-beta structure from a pharmaceutical composition |
WO2007035405A2 (en) * | 2005-09-16 | 2007-03-29 | University Of Pittsburgh | In-vivo and in-vitro method for detecting amyloid deposits having at least one amyloidogenic protein |
KR100778888B1 (ko) * | 2005-11-29 | 2007-11-28 | 재단법인서울대학교산학협력재단 | 베타아밀로이드 펩타이드 플라크의 영상화를 위한벤질리덴아닐린 계열의 유도체 및 그의 방사성 동위원소표지화합물 |
US8022075B2 (en) | 2005-11-30 | 2011-09-20 | Fujifilm Ri Pharma Co., Ltd. | Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition |
EP1971584A2 (en) * | 2005-12-01 | 2008-09-24 | University of Pittsburgh - Of the Commonwealth System of Higher Education | Isotopically-labeled benzothiazole compounds as imaging agents for amyloidogenic proteins |
WO2007075595A2 (en) * | 2005-12-20 | 2007-07-05 | Vertex Pharmacueticals Incorporated | Biofilm assay |
US7781187B2 (en) * | 2005-12-30 | 2010-08-24 | Corning Incorporated | Fluorescent dyes |
TW200736252A (en) | 2006-01-27 | 2007-10-01 | Astrazeneca Ab | Novel heteroaryl substituted benzothiazoles |
KR101426093B1 (ko) | 2006-02-10 | 2014-08-01 | 서미트 코포레이션 피엘씨 | 뒤시엔느 근이영양증의 치료 |
JP5182747B2 (ja) * | 2006-03-28 | 2013-04-17 | 国立大学法人滋賀医科大学 | 神経難病の画像診断薬 |
TW200803903A (en) * | 2006-04-28 | 2008-01-16 | Nihon Mediphysics Co Ltd | Novel compound having affinity to amyloid |
WO2008118122A2 (en) * | 2006-05-08 | 2008-10-02 | Molecular Neuroimaging, Llc | Compounds and amyloid probes thereof for therapeutic and imaging uses |
AU2007252658B2 (en) | 2006-05-19 | 2012-03-29 | Nihon Medi-Physics Co., Ltd. | Novel compound having affinity for amyloid |
TW200813035A (en) | 2006-06-19 | 2008-03-16 | Astrazeneca Ab | Novel heteroaryl substituted benzoxazoles |
KR20090025282A (ko) | 2006-06-21 | 2009-03-10 | 니혼 메디피직스 가부시키가이샤 | 신규 아밀로이드 친화성 화합물 |
WO2008015391A1 (en) * | 2006-08-03 | 2008-02-07 | Hammersmith Imanet Limited | Method for the purification of radiolabelled compounds |
NZ577511A (en) | 2006-11-30 | 2012-04-27 | Nihon Mediphysics Co Ltd | 2-Phenyl-imidazo[1,2-a]pyridine derivatives substituted with a radioactive halogen substituent |
CN101668560A (zh) * | 2006-12-07 | 2010-03-10 | 宾夕法尼亚大学理事会 | 乙炔衍生物及它们在结合和显像淀粉样斑块中的应用 |
JP5468905B2 (ja) * | 2007-01-30 | 2014-04-09 | ジーイー・ヘルスケア・リミテッド | 神経変性疾患の診断を支援するためのツール |
TWI406674B (zh) | 2007-02-13 | 2013-09-01 | Nihon Mediphysics Co Ltd | Method for manufacturing diagnostic radiographic diagnostic agents |
TW200901998A (en) | 2007-03-06 | 2009-01-16 | Astrazeneca Ab | Novel 2-heteroaryl substituted benzothiophenes and benzofuranes |
CN101293878B (zh) * | 2007-04-25 | 2010-12-15 | 中国科学院上海应用物理研究所 | 苯并噻唑苯胺类化合物及其制备方法和应用 |
PT2170396T (pt) | 2007-08-03 | 2017-03-31 | Summit Corp Plc | Combinação de fármacos para o tratamento da distrofia muscular de duchenne |
CN101790387B (zh) | 2007-08-30 | 2013-03-20 | 通用电气健康护理有限公司 | 放射性药物组合物 |
JPWO2009054496A1 (ja) * | 2007-10-24 | 2011-03-10 | 日本メジフィジックス株式会社 | 新規アミロイド親和性化合物 |
JP5313158B2 (ja) | 2007-10-26 | 2013-10-09 | 日本メジフィジックス株式会社 | 新規アミロイド親和性化合物 |
CA2704139A1 (en) | 2007-10-30 | 2009-05-07 | Nihon Medi-Physics Co., Ltd. | Utilization of novel compounds with amyloid affinity and method of producing the same |
EP2216051A1 (en) * | 2007-10-30 | 2010-08-11 | Nihon Medi-Physics Co., Ltd. | Use of novel compound having affinity for amyloid, and process for production of the same |
US20090123373A1 (en) * | 2007-11-05 | 2009-05-14 | Yanming Wang | Amyloid-imaging agents |
EP2058001A1 (en) * | 2007-11-08 | 2009-05-13 | Crossbeta Biosciences B.V. | Enhancement of immunogenicity of antigens |
EP2058000A1 (en) * | 2007-11-08 | 2009-05-13 | Crossbeta Biosciences B.V. | Immunogenic compositions capable of activating T cells |
WO2009155024A1 (en) * | 2008-05-30 | 2009-12-23 | Merck & Co., Inc. | Novel substituted indoles |
ES2554772T3 (es) | 2008-05-30 | 2015-12-23 | Merck Sharp & Dohme Corp. | Azabenzoxazoles sustituidos novedosos |
RU2010154473A (ru) * | 2008-05-30 | 2012-07-10 | Фостер Вилер Энергия Ой (Fi) | Способ и устройство для генерации мощности сжиганием обогащенного кислородом топлива |
AU2009266098B2 (en) | 2008-06-09 | 2015-01-22 | Ludwig-Maximilians-Universitat Munchen | New drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases |
US20100099609A1 (en) * | 2008-07-28 | 2010-04-22 | Buck Institute For Age Research | eAPP AND DERIVATIVES FOR TREATMENT OF ALZHEIMER'S DISEASE |
EP2910945B1 (en) | 2008-09-30 | 2018-07-18 | Case Western Reserve University | Molecular probes for imaging of myelin |
WO2010053218A1 (en) * | 2008-11-06 | 2010-05-14 | Snu R&Db Foundation | Fluorinated benzothiazole derivatives, preparation method thereof and imaging agent for diagnosing altzheimer's disease using the same |
US20100129290A1 (en) * | 2008-11-26 | 2010-05-27 | I.S.T. Corporation | Smart contrast agent and detection method for detecting transition metal ions |
CN101598703B (zh) * | 2009-07-03 | 2012-08-22 | 中国人民解放军第三军医大学第一附属医院 | dGTpase蛋白在制备用于鉴别诊断唐氏胎儿药物中的应用 |
FR2948685A1 (fr) * | 2009-07-30 | 2011-02-04 | Biomerieux Sa | Nouveaux substrats |
US20110081428A1 (en) * | 2009-09-16 | 2011-04-07 | The Buck Institute For Age Research | Use of thioflavin-like compounds to increase life span and/or health span |
DE102010045797A1 (de) | 2010-09-20 | 2012-03-22 | Klinikum Darmstadt Gmbh | Verbindungen für die Diagnostik neurodegenerativer Erkrankungen am Riechepithel |
WO2012041292A2 (de) | 2010-09-20 | 2012-04-05 | Klinikum Darmstadt Gmbh | Verbindungen für die diagnostik neurodegenerativer erkrankungen an der retina |
JP5272110B2 (ja) | 2011-05-20 | 2013-08-28 | 日本メジフィジックス株式会社 | 新規アミロイド親和性化合物 |
CA2839199C (en) | 2011-06-24 | 2018-11-06 | Nihon Medi-Physics Co., Ltd. | Novel compound with amyloid affinity |
WO2013027694A1 (ja) * | 2011-08-24 | 2013-02-28 | 国立大学法人京都大学 | コンフォメーション病診断用分子イメージングプローブ |
EP2755961A1 (en) | 2011-09-16 | 2014-07-23 | Pfizer Inc | Solid forms of a transthyretin dissociation inhibitor |
CN102526765B (zh) * | 2011-12-31 | 2014-07-30 | 郑州泰基鸿诺药物科技有限公司 | 一种Aβ斑块显像剂及其制备方法 |
KR20130111082A (ko) * | 2012-03-30 | 2013-10-10 | 한미약품 주식회사 | 베타-아밀로이드 피브릴 형성 저해 효능을 갖는 아미노스티릴벤조퓨란 화합물 및 이를 함유하는 약학 조성물 |
WO2014032732A1 (de) | 2012-08-28 | 2014-03-06 | Eberhard Karls Universität Tübingen Medizinische Fakultät | Halogenierte benzoxazine und ihre verwendung |
EP2890700B1 (de) * | 2012-08-28 | 2017-12-13 | Eberhard Karls Universität Tübingen Medizinische Fakultät | Halogenierte benzoxazine und ihre verwendung |
KR20190136125A (ko) | 2012-12-21 | 2019-12-09 | 국립연구개발법인 양자과학기술연구개발기구 | 뇌 안에 축적된 타우 단백질을 이미징하기 위한 신규한 화합물 |
US9246108B2 (en) | 2012-12-28 | 2016-01-26 | Dow Global Technologies Llc | Quinoline-benzoxazole derived compounds for electronic films and devices |
US9889199B2 (en) | 2013-02-15 | 2018-02-13 | Case Western Reserve University | PSMA ligands and uses thereof |
CN105579453B (zh) | 2013-09-26 | 2017-12-22 | 豪夫迈·罗氏有限公司 | 作为成像工具的咪唑并[1,2‑a]吡啶‑7‑胺类 |
WO2015051188A1 (en) | 2013-10-02 | 2015-04-09 | Washington University | Heterocyclic molecules for biomedical imaging and therapeutic applications |
WO2015162870A1 (ja) | 2014-04-24 | 2015-10-29 | 想い出創造株式会社 | アミロイド線維形成の抑制又は阻害剤 |
CN104059028B (zh) * | 2014-06-06 | 2020-10-16 | 北京智博高科生物技术有限公司 | 与Aβ斑块具有亲和力的含手性侧链取代的氟代2-芳基苯并杂环化合物、其制备方法及应用 |
JP6498412B2 (ja) * | 2014-10-17 | 2019-04-10 | 国立大学法人群馬大学 | 新規チオフラビンt誘導体及びその利用 |
US9842938B2 (en) | 2015-03-24 | 2017-12-12 | Semiconductor Energy Laboratory Co., Ltd. | Semiconductor device and display device including semiconductor device |
EP3426309B1 (en) | 2016-03-09 | 2022-05-04 | Case Western Reserve University | Radioligands for myelin |
CA3224365A1 (en) * | 2016-03-11 | 2017-09-14 | Ac Immune Sa | Bicyclic compounds for diagnosis and therapy of alpha-synuclein associated disorders |
WO2018062588A1 (ko) | 2016-09-29 | 2018-04-05 | 한국원자력연구원 | 커큐민 유도체, 이의 제조방법 및 이를 포함하는 베타-아밀로이드 플라크 검출용 광음향 영상화제 |
IL278013B2 (en) | 2018-04-18 | 2024-01-01 | Constellation Pharmaceuticals Inc | Modulators of secondary methyl enzymes, preparations and uses thereof |
US11167283B2 (en) | 2018-05-04 | 2021-11-09 | University Of South Carolina | Dot blot box and use thereof |
EP3797108B1 (en) | 2018-05-21 | 2022-07-20 | Constellation Pharmaceuticals, Inc. | Modulators of methyl modifying enzymes, compositions and uses thereof |
AU2020383593A1 (en) | 2019-11-13 | 2022-06-09 | Aprinoia Therapeutics Limited | Compounds for degrading Tau protein aggregates and uses thereof |
KR102426160B1 (ko) | 2020-07-13 | 2022-07-29 | (주)바이오액츠 | 알츠하이머 진단용 신규 형광화합물 및 이의 제조방법 |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA241942A (en) | 1924-08-05 | Martinetto Vittorio | Asynchronous machine | |
BE581862A (lt) * | 1958-08-22 | |||
DE3148291A1 (de) * | 1981-12-05 | 1983-06-09 | Basf Ag, 6700 Ludwigshafen | Harnstoffderivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses |
DE3307364A1 (de) | 1983-03-02 | 1984-09-06 | Hoechst Ag, 6230 Frankfurt | Zweikomponenten-diazontypiematerial |
US4666829A (en) | 1985-05-15 | 1987-05-19 | University Of California | Polypeptide marker for Alzheimer's disease and its use for diagnosis |
US4933156A (en) * | 1987-04-08 | 1990-06-12 | Salutar, Inc. | Amyloidosis and Alzheimer's disease diagnostic assay and reagents therefor |
AU620327B2 (en) * | 1987-04-08 | 1992-02-20 | Salutar, Inc. | Amyloidosis and alzheimer's disease diagnostic assay and reagents therefor |
CA1339014C (en) | 1987-10-08 | 1997-03-25 | Ronald E. Majocha | Antibodies to a4 amyloid peptide |
US5231000A (en) | 1987-10-08 | 1993-07-27 | The Mclean Hospital | Antibodies to A4 amyloid peptide |
US5297562A (en) | 1991-04-01 | 1994-03-29 | President And Fellows Of Harvard College | Method for detecting and treating Alzheimer's disease |
US5434050A (en) | 1991-08-13 | 1995-07-18 | Regents Of The University Of Minnesota | Labelled β-amyloid peptide and methods of screening for Alzheimer's disease |
GB9317949D0 (en) * | 1993-08-28 | 1993-10-13 | Stevens Malcolm F G | Benzothiazole compounds |
CA2182731A1 (en) | 1994-02-03 | 1995-08-10 | Michael P. Vitek | Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis |
US6417178B1 (en) * | 1994-07-19 | 2002-07-09 | University Of Pittsburgh | Amyloid binding nitrogen-linked compounds for the antemortem diagnosis of alzheimer's disease, in vivo imaging and prevention of amyloid deposits |
US6168776B1 (en) * | 1994-07-19 | 2001-01-02 | University Of Pittsburgh | Alkyl, alkenyl and alkynyl Chrysamine G derivatives for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
GB9503946D0 (en) * | 1995-02-28 | 1995-04-19 | Cancer Res Campaign Tech | Benzazole compounds |
CA2219880A1 (en) | 1995-05-01 | 1996-11-07 | University Of Pittsburgh | Azocompounds for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
US6001331A (en) | 1996-01-24 | 1999-12-14 | Warner-Lambert Company | Method of imaging amyloid deposits |
EP0973513A4 (en) * | 1996-10-23 | 2003-03-19 | Zymogenetics Inc | COMPOSITIONS AND METHODS FOR TREATING CONDITIONS ASSOCIATED WITH BONE DEFICIT |
TR199901132T2 (xx) | 1996-11-22 | 1999-08-23 | Elan Pharmaceuticals, Inc. | N-(aril/heteoaril) amino asit t�revleri, bunlar� i�eren farmas�tik bile�imler ve b�yle bile�ikler kullan�larak �-amiloid peptidinin sal�nmas�n� ve/veya sentezini inhibe etmek i�in y�ntemler. |
US6348478B1 (en) * | 1997-11-20 | 2002-02-19 | Teijin Limited | Biphenylamidine derivatives |
WO2000002004A2 (en) | 1998-06-30 | 2000-01-13 | Kevin Mcclung | Controlled-penetration projectile |
GB9919673D0 (en) * | 1999-08-20 | 1999-10-20 | Cancer Res Campaign Tech | 2-Arlybenzazole compounds |
US7270800B2 (en) * | 2000-08-24 | 2007-09-18 | University Of Pittsburgh | Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
PT2264018E (pt) | 2000-08-24 | 2015-06-03 | Univ Pittsburgh | Derivados de tioflavina para uso no diagnóstico da doença de alzheimer |
EP1345914A1 (en) | 2000-12-22 | 2003-09-24 | AstraZeneca AB | Therapeutic compounds |
WO2002085903A2 (en) * | 2001-04-23 | 2002-10-31 | The Trustees Of The University Of Pennsylvania | Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
GB0229686D0 (en) | 2002-12-20 | 2003-01-29 | Amersham Plc | Solid-phase fluorination of benzothiazoles |
CN102532055B (zh) * | 2003-03-14 | 2016-05-11 | 匹兹堡大学联邦制高等教育 | 苯并噻唑衍生物化合物、组合物及用途 |
US8236282B2 (en) * | 2003-08-22 | 2012-08-07 | University of Pittsburgh—of the Commonwealth System of Higher Education | Benzothiazole derivative compounds, compositions and uses |
CA2587248C (en) * | 2004-07-02 | 2014-01-07 | William E. Klunk | Amyloid imaging as a surrogate marker for efficacy of anti-amyloid therapies |
WO2007047204A1 (en) * | 2005-10-11 | 2007-04-26 | University Of Pittsburgh | Isotopically-labeled benzofuran compounds as imagingagents foramyloidogenic proteins |
-
2001
- 2001-08-24 PT PT101856698T patent/PT2264018E/pt unknown
- 2001-08-24 ES ES10185669.8T patent/ES2536449T3/es not_active Expired - Lifetime
- 2001-08-24 HU HU1500560A patent/HU230581B1/hu unknown
- 2001-08-24 RU RU2003108256/04A patent/RU2324686C2/ru not_active IP Right Cessation
- 2001-08-24 ES ES01966165T patent/ES2395721T3/es not_active Expired - Lifetime
- 2001-08-24 WO PCT/US2001/026427 patent/WO2002016333A2/en active Application Filing
- 2001-08-24 EP EP10185669.8A patent/EP2264018B1/en not_active Expired - Lifetime
- 2001-08-24 DK DK10185669.8T patent/DK2264018T3/en active
- 2001-08-24 AU AU8670201A patent/AU8670201A/xx active Pending
- 2001-08-24 US US09/935,767 patent/US20020133019A1/en not_active Abandoned
- 2001-08-24 EP EP01966165A patent/EP1334091B1/en not_active Expired - Lifetime
- 2001-08-24 BR BRPI0113470-1 patent/BRPI0113470B8/pt not_active IP Right Cessation
- 2001-08-24 PL PL360550A patent/PL215711B1/pl unknown
- 2001-08-24 JP JP2002521434A patent/JP5022554B2/ja not_active Expired - Lifetime
- 2001-08-24 CN CNB018178847A patent/CN1285582C/zh not_active Expired - Lifetime
- 2001-08-24 HU HU0302956A patent/HU230375B1/hu unknown
- 2001-08-24 CA CA2419420A patent/CA2419420C/en not_active Expired - Lifetime
- 2001-08-24 AU AU2001286702A patent/AU2001286702B2/en not_active Expired
- 2001-08-24 SI SI200131017T patent/SI1334091T1/sl unknown
- 2001-08-24 DK DK01966165.1T patent/DK1334091T3/da active
- 2001-08-24 PT PT1966165T patent/PT1334091E/pt unknown
-
2003
- 2003-02-24 NO NO20030860A patent/NO330176B1/no not_active IP Right Cessation
-
2004
- 2004-02-09 HK HK04100858.7A patent/HK1058041A1/xx not_active IP Right Cessation
- 2004-06-03 US US10/859,600 patent/US7351401B2/en not_active Expired - Lifetime
-
2008
- 2008-03-11 US US12/046,070 patent/US20080154042A1/en not_active Abandoned
- 2008-06-13 AU AU2008202626A patent/AU2008202626B9/en not_active Expired
-
2011
- 2011-01-27 HK HK11100858.8A patent/HK1146725A1/xx not_active IP Right Cessation
- 2011-12-02 US US13/310,243 patent/US20120095235A1/en not_active Abandoned
- 2011-12-06 JP JP2011266396A patent/JP2012102106A/ja active Pending
-
2012
- 2012-11-06 CY CY20121101055T patent/CY1113311T1/el unknown
-
2015
- 2015-01-13 US US14/595,949 patent/US9833458B2/en not_active Expired - Lifetime
- 2015-01-19 LT LTPA2015001C patent/LTC1334091I2/lt unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LTC1334091I2 (lt) | Tioflavino dariniai ir jų panaudojimas Alzhaimerio ligos diagnostikai ir terapijai | |
CY2020003I1 (el) | Anti-il-12 αντισωματα, συνθεσεις, μεθοδοι και χρησεις για την θεραπευτικη αγωγη της παθολογιας του crohn | |
NO20022531D0 (no) | Vaksine for forebyggelse og behandling av Alzheimer og amyloidrelaterte sykdommer | |
CY2018020I2 (el) | Θεραπεια της νοσου ρομρε | |
EE200200716A (et) | Ühendid Alzheimeri tõve käitluseks | |
AU2001249835A1 (en) | Diagnosis and treatment of alzheimer's disease | |
IL188506A0 (en) | Use of an immunogen for preparation of pharmaceutical composition for treating alzheimer's disease | |
SI1303272T1 (sl) | Derivati benzotiazola za zdravljenje alzheimerjeve bolezni in parkinsonove bolezni | |
HUP0301020A3 (en) | Early diagnosis of conformational diseases | |
EP1817050A4 (en) | DIAGNOSIS AND TREATMENT OF MORBUS ALZHEIMER | |
EE200300216A (et) | Radiofarmatseutilised ained Alzheimeri tõve diagnoosimiseks | |
NO20001869D0 (no) | Fremgangsmõte for behandling av Alzheimerssykdom | |
ID27576A (id) | Penggunaan siklosporin dalam pengobatan penyakit-penyakit peradangan autoimun | |
AU2002222108A1 (en) | Diagnosis and treatment of alzheimer's disease | |
IL172213A0 (en) | Compounds useful in the therapy of alzheimer's disease and formulations containing them | |
AU5550800A (en) | Diagnosis and treatment of alzheimer's disease | |
NO20024746L (no) | Anvendelse av galantamin ved behandling av nevropsykiatrisk oppförsel assosiert med Alzheimers sykdom | |
NO20012612L (no) | Isonipecotamider for behandlingen av integrin-formidlede sykdommer | |
AU2003289859A1 (en) | Diagnostic and therapeutic use of arl7 for alzheimer's disease | |
GB0008162D0 (en) | Diagnosis and treatment of alzheimer's disease | |
AU2003251709A1 (en) | Diagnostic and therapeutic use of proteolipid protein for alzheimer's disease | |
ITMI20002172A0 (it) | Specola divaricabile per trattamenti idroterapeutici dell'intestino | |
GB0121046D0 (en) | The diagnosis and treatment of airways disease | |
AU2002333808A1 (en) | Diagnostic and therapeutic use of f-box proteins for alzheimer's disease and related neurodegenerative disorders | |
GB0026738D0 (en) | Diagnosis and therapeutic targeting of alzheimers disease in humans |